滚动 来源:证券之星网站 时间:2026-06-18 17:10:58
(相关资料图)
我武生物(300357.SZ)公告称,公司获得国家药监局《受理通知书》,其提交的“猫毛膜剂"药物临床试验申请已正式受理。该产品为治疗用生物制品1类,适应症用于猫毛皮屑致敏相关的变应性鼻炎的成人患者。
26-06-17
26-06-17
26-06-16
26-06-16
26-06-15
26-06-14
26-06-12
26-06-11
26-06-10
26-06-10
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-15
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-14
26-06-13
26-06-13
26-06-13
26-06-13
26-06-13
26-06-13
26-06-13
26-06-13
26-06-13
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
26-06-18
26-06-18
26-06-18
26-06-17
26-06-17
26-06-16
26-06-16
26-06-15
26-06-15
26-06-13
26-06-13
23-07-10
